CTRI/2009/091/000651招募中2 期
A Randomized, Double-Blind, Double-Dummy, Paralle Group Study to Compare YM150 bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery.Acronym: ONYX-3
试验速览
- 阶段
- 2 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male or female subject aged 18 years or older.
- •Subject is scheduled for elective hip replacement surgery.
排除标准
- •- Subject has active bleeding or any condition associated with increased risk of bleeding
- •- Subject has had major trauma or surgery within 3 months before planned hip replacement surgery or requires major surgery or other invasive procedures with potential for uncontrolled bleeding during the study
- •- Subject has had an MI or stroke within 3 months before planned hip replacement surgery
研究者
相似试验
进行中（未招募）
1 期
A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment with Ropinirole Immediate Release (IR) Tablets or Ropinirole Prolonged Release / Extended Release (PR/XR) Tablets in Advanced Stage Parkinson’s Disease Subjects who are not Adequately Controlled on L-dopa.Parkinson's diseaseEUCTR2005-005423-34-GBGlaxoSmithKline Research & Development Ltd
进行中（未招募）
不适用
A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment with Ropinirole Immediate Release IR Tablets or Ropinirole Prolonged Release / Extended Release PR/XR Tablets in Advanced Stage Parkinson s Disease Subjects who are not Adequately Controlled on L-dopa. - NDParkinson diseaseMedDRA version: 6.1Level: PTClassification code 10061536EUCTR2005-005423-34-ITGlaxoSmithKline R D516
进行中（未招募）
不适用
A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Major Depressive DisorderMajor Depressive DisordersMedDRA version: 9.1Level: LLTClassification code 10057840Term: Major depressionEUCTR2004-004984-32-ITGLAXO SMITHKLINE500
进行中（未招募）
不适用
A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Major Depressive DisorderEUCTR2004-004984-32-SEGlaxoSmithKline Research and Development Limited348
已完成
3 期
A Randomised, Double-Blind, Double-Dummy, Parallel-Group, Multicentre Study to assess efficacy and safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and Fluticasone Propionate FP)/Salmeterol Inhalation Powder in the Treatment of Persistent Asthma in Adults and Adolescents.Persistent Asthma10006436AsthmaNL-OMON34054GlaxoSmithKline62